We are thrilled to announce that Gray has been selected for the inaugural cohort of startups in CancerX’s Accelerator program! Â
Announced on stage at ViVE 2024, the group was selected from a robust list of startup applicants who shared their ideas for digital innovation – in the area of clinical research; screening and diagnosis; treatment and management; clinical operations; or patient, caregiver, and survivor experience – aiming to reduce the burden of cancer for all people.Â
A team of Accelerator Champions and judges from the CancerX community led three rounds of judging earlier this year to select this impressive cohort group. The full list of startups includes: The Blue Box, C the Signs, Cancer Insights, Curvia, EnteroTrack, Gesund.ai, Gray Oncology, LindAI, Mika Health, Navya, Oatmeal Health, Orbit Genomics, Realyze Intelligence, Reimagine Care, Survivor Plan, and Xanthos.
As a member of this cohort, we will now participate in a rich, 4-month program where we will:
Engage with members of the healthcare ecosystem to test and validate their solutions.
Get expert guidance from CancerX Mentors.
Graduate with a roadmap to successfully scale our company, an opportunity to move forward with our sponsor, and a community that will continue to support our development.
This partnership will accelerate Gray's expansion across North America, in line with our mission to optimize cancer care trajectories so that more and more patients receive efficient, sustainable and equitable care.
About CancerX Accelerator: CancerX Accelerator uniquely brings together a community of champions, innovators, and users of digital health in oncology to generate and scale ideas that have the potential to solve unmet needs in clinical delivery for cancer patients and providers. Â
Sign up to receive information about CancerX news.